Physician response to financial incentives when choosing drugs to treat breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physician response to financial incentives when choosing drugs to treat breast cancer

Published:2012-11-03 Issue:4 Volume:12 Page:285-302
ISSN:1389-6563
Container-title:International Journal of Health Care Finance and Economics
language:en
Short-container-title:Int J Health Care Finance Econ

Author:

Epstein Andrew J.,Johnson Scott J.

Publisher

Springer Science and Business Media LLC

Subject

General Economics, Econometrics and Finance,Finance,General Medicine,Health(social science)

Link

http://link.springer.com/content/pdf/10.1007/s10754-012-9117-y.pdf

Reference44 articles.

1. Afendulis C. C., Kessler D. (2007) Tradeoffs from integrating diagnosis and treatment in markets for health care. American Economic Review 97(3): 1013–1020

2. Alexander G., Casalino L., Meltzer D. (2003) Patient–physician communication about out-of-pocket costs. Journal of the American Medical Association 290: 953–958

3. Allison P., Christakis N. (1994) Logit models for sets of ranked items. Sociological Methods 24: 199–228

4. Azoulay P. (2002) Do pharmaceutical sales respond to scientific evidence?. Journal of Economics and Management Strategy 11(4): 551–594

5. Bach P. B. (2009) Limits on Medicare’s ability to control rising spending on cancer drugs. New England Journal of Medicine 360(6): 626–633

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Physician Payment Scheme on Diagnostic Effort and Testing;Management Science;2023-10-26

2. Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer;European Journal of Medicinal Chemistry;2021-01

3. TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines;Trends in Cancer;2020-02

4. Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan;International Health;2019-10-24

5. Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice;The Oncologist;2019-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3